SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Pro Dex Inc. – ‘10-K’ for 6/30/22 – ‘EX-4.1’

On:  Thursday, 9/8/22, at 4:00pm ET   ·   For:  6/30/22   ·   Accession #:  1553350-22-745   ·   File #:  0-14942

Previous ‘10-K’:  ‘10-K’ on 9/9/21 for 6/30/21   ·   Next & Latest:  ‘10-K’ on 10/13/23 for 6/30/23   ·   19 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/08/22  Pro Dex Inc.                      10-K        6/30/22   81:5.8M                                   Edgar Filing LLC/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.05M 
 2: EX-4.1      Description of the Company's Common Stock           HTML     25K 
 3: EX-23       Consent of Expert or Counsel                        HTML     23K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 6: EX-32       Certification -- §906 - SOA'02                      HTML     23K 
12: R1          Cover                                               HTML     87K 
13: R2          Consolidated Balance Sheets                         HTML    130K 
14: R3          Consolidated Balance Sheets (Parenthetical)         HTML     33K 
15: R4          Consolidated Income Statements                      HTML    116K 
16: R5          Consolidated Statements of Shareholders' Equity     HTML     74K 
17: R6          Consolidated Statements of Cash Flows               HTML    126K 
18: R7          Description of Business                             HTML     26K 
19: R8          Summary of Significant Accounting Policies          HTML     61K 
20: R9          Revision of Previously Issued Financial Statements  HTML     27K 
                for Correction of Immaterial Errors                              
21: R10         Net Sales                                           HTML     45K 
22: R11         Composition of Certain Financial Statement Items    HTML     78K 
23: R12         Warranty Accrual                                    HTML     32K 
24: R13         Income Taxes                                        HTML     83K 
25: R14         Notes Payable and Financing Transactions            HTML     56K 
26: R15         Leases                                              HTML     33K 
27: R16         Commitments and Contingencies                       HTML     32K 
28: R17         Share-Based Compensation                            HTML    116K 
29: R18         Major Customers & Suppliers                         HTML     93K 
30: R19         Net Income Per Share                                HTML     35K 
31: R20         COMMON STOCK - Share Repurchase Program             HTML     34K 
32: R21         Subsequent Events                                   HTML     25K 
33: R22         Summary of Significant Accounting Policies          HTML    109K 
                (Policies)                                                       
34: R23         Summary of Significant Accounting Policies          HTML     26K 
                (Tables)                                                         
35: R24         Net Sales (Tables)                                  HTML     42K 
36: R25         Composition of Certain Financial Statement Items    HTML     71K 
                (Tables)                                                         
37: R26         Warranty Accrual (Tables)                           HTML     31K 
38: R27         Income Taxes (Tables)                               HTML     82K 
39: R28         Notes Payable and Financing Transactions (Tables)   HTML     29K 
40: R29         Leases (Tables)                                     HTML     30K 
41: R30         Share-Based Compensation (Tables)                   HTML     88K 
42: R31         Major Customers & Suppliers (Tables)                HTML     95K 
43: R32         Net Income Per Share (Tables)                       HTML     33K 
44: R33         Summary of Significant Accounting Policies          HTML     30K 
                (Details)                                                        
45: R34         Summary of Significant Accounting Policies          HTML     45K 
                (Details Narrative)                                              
46: R35         Revision of Previously Issued Financial Statements  HTML     29K 
                for Correction of Immaterial Errors (Details                     
                Narrative)                                                       
47: R36         Net Sales (Net sales) (Details)                     HTML     34K 
48: R37         Net Sales (Contract assets and liability)           HTML     37K 
                (Details)                                                        
49: R38         Net Sales (Details Narrative)                       HTML     26K 
50: R39         Composition of Certain Financial Statement Items    HTML     29K 
                (Schedule of investments) (Details)                              
51: R40         Composition of Certain Financial Statement Items    HTML     32K 
                (Inventory) (Details)                                            
52: R41         Composition of Certain Financial Statement Items    HTML     32K 
                (Schedule of Land and Building) (Details)                        
53: R42         Composition of Certain Financial Statement Items    HTML     39K 
                (Schedule of Equipment and improvements )                        
                (Details)                                                        
54: R43         Composition of Certain Financial Statement Items    HTML     31K 
                (Intangible Assets) (Details)                                    
55: R44         Composition of Certain Financial Statement Items    HTML     42K 
                (Accrued liabilities) (Details)                                  
56: R45         Composition of Certain Financial Statement Items    HTML     56K 
                (Details Narrative)                                              
57: R46         Warranty Accrual (Schedule of accrual warranty      HTML     31K 
                costs) (Details)                                                 
58: R47         Warranty Accrual (Details Narrative)                HTML     24K 
59: R48         Income Taxes (Provision for income tax expense)     HTML     39K 
                (Details)                                                        
60: R49         Income Taxes (Effective income tax rate on loss     HTML     62K 
                from continuing operations) (Details)                            
61: R50         Income Taxes (Deferred tax assets and liabilities   HTML     61K 
                for federal and state income taxes) (Details)                    
62: R51         Income Taxes (Accrual for unrecognized tax          HTML     33K 
                benefits) (Details)                                              
63: R52         Income Taxes (Details Narrative)                    HTML     27K 
64: R53         Notes Payable and Financing Transactions (Schedule  HTML     43K 
                of Maturities of Term Loan for Future Fiscal                     
                Years) (Details)                                                 
65: R54         Notes Payable and Financing Transactions (Details   HTML     70K 
                Narrative)                                                       
66: R55         Leases (Schedule of Future Minimum Base Rental      HTML     41K 
                Payment) (Details)                                               
67: R56         Leases (Details Narrative)                          HTML     28K 
68: R57         Commitments and Contingencies (Details Narrative)   HTML     34K 
69: R58         Share-Based Compensation (Summary of Stock Option   HTML     50K 
                Activity) (Details)                                              
70: R59         Share-Based Compensation (Performance awards        HTML     43K 
                activity) (Details)                                              
71: R60         Share-Based Compensation (Non-qualified stock       HTML     50K 
                option activity) (Details)                                       
72: R61         Share-Based Compensation (Details Narrative)        HTML    101K 
73: R62         Major Customers & Suppliers (Sales) (Details)       HTML     44K 
74: R63         Major Customers and Suppliers                       HTML     65K 
                (AccountsReceivablePayable) (Details)                            
75: R64         Net Income Per Share (Details)                      HTML     55K 
76: R65         COMMON STOCK - Share Repurchase Program (Details    HTML     35K 
                Narrative)                                                       
79: XML         IDEA XML File -- Filing Summary                      XML    147K 
77: XML         XBRL Instance -- pdex_10k_htm                        XML   1.27M 
78: EXCEL       IDEA Workbook of Financial Reports                  XLSX    126K 
 8: EX-101.CAL  XBRL Calculations -- pdex-20220630_cal               XML    218K 
 9: EX-101.DEF  XBRL Definitions -- pdex-20220630_def                XML    386K 
10: EX-101.LAB  XBRL Labels -- pdex-20220630_lab                     XML   1.00M 
11: EX-101.PRE  XBRL Presentations -- pdex-20220630_pre              XML    776K 
 7: EX-101.SCH  XBRL Schema -- pdex-20220630                         XSD    152K 
80: JSON        XBRL Instance as JSON Data -- MetaLinks              376±   544K 
81: ZIP         XBRL Zipped Folder -- 0001553350-22-000745-xbrl      Zip    272K 


‘EX-4.1’   —   Description of the Company’s Common Stock


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



EXHIBIT 4.1

Description of the Company’s Common Stock
Registered Pursuant to Section 12 of the
Securities Exchange Act of 1934

The following summary of Pro-Dex, Inc.’s common stock does not purport to be complete and is subject to and qualified in its entirety by reference to our Articles of Incorporation, as amended (Articles of Incorporation), and Amended and Restated Bylaws (Bylaws). For a complete description of the terms and provisions of our capital stock, including our common stock, refer to the Articles of Incorporation and the Bylaws, which are filed as exhibits to this Annual Report on Form 10-K.

General

s of September 6, 2022, our authorized capital stock consists of (i) 50,000,000 shares of common stock, no par value per share, and (ii) 10,000,000 shares of preferred stock, no par value per share. As of September 6, 2022, 3,619,189 shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding. Our common stock is our only class of securities registered under Section 12 of the Securities Exchange Act of 1934.

Common Stock

The holders of our common stock are entitled to one vote for each share of common stock held of record on all matters submitted to a vote of our shareholders, including the election of directors, and do not have cumulative voting rights. Subject to preferences that may be applicable to any outstanding of our preferred stock, holders of common stock are entitled to receive ratably those dividends, if any, as may be declared by our Board of Directors out of legally available funds. Subject to the rights of any outstanding preferred stock, upon the Company’s liquidation, dissolution or winding-up, the holders of common stock will be entitled to share ratably in the net assets legally available for distribution to our shareholders after the payment of all of our debts and other liabilities. Holders of common stock have no preemptive or conversion rights or other subscription rights and there are no redemption or sinking fund provisions applicable to our common stock. All outstanding shares of common stock are fully paid and nonassessable.

Our Board of Directors has the authority, without further action by our shareholders (other than such approval rights as may be granted to any outstanding series of preferred stock), to designate and issue one or more series of preferred stock and to fix the rights, powers, preferences, qualifications, limitations and restrictions of each series of preferred stock to the maximum extent permitted by Colorado law. The issuance of preferred stock could decrease the amount of earnings and assets available for distribution to holders of common stock or adversely affect the rights and powers, including voting rights, of the holders of common stock. The existence of authorized but unissued preferred stock may also discourage or render more difficult attempts to take control of the Company, as described in more detail below under “Anti-Takeover Provisions of Governing Documents.”

Broadridge Corporate Issuer Solutions, Inc. is the transfer agent for our common stock.

Our common stock is listed on the NASDAQ Capital Market under the symbol “PDEX”.

Anti-Takeover Provisions of Governing Documents

Our Bylaws require that our shareholders satisfy certain advance notice and other requirements in order to properly submit proposals or director nominees for consideration at our annual meetings of shareholders.

As discussed above, our Board of Directors has the authority, without further action by our shareholders (other than such approval rights as may be granted to any outstanding series of preferred stock), to designate and issue one or more series of preferred stock and to fix the rights, powers, preferences, qualifications, limitations, and restrictions of each series of preferred stock to the maximum extent permitted by Colorado law. The existence of authorized but unissued preferred stock may enable our Board of Directors to render more difficult or to discourage an attempt to obtain control of the Company by means of a merger, tender offer, proxy contest or otherwise. Among other things, if in the due exercise of its fiduciary obligations, our Board of Directors were to determine that a takeover proposal is not in the best interests of the Company and our shareholders, our Board of Directors could cause shares of preferred stock to be designated and issued without further shareholder approval in one or more private offerings or other transactions that might dilute the voting or other rights of the proposed acquirer or insurgent shareholder or shareholder group.

 

 


Dates Referenced Herein

This ‘10-K’ Filing    Date    Other Filings
Filed on:9/8/22None on these Dates
9/6/22
For Period end:6/30/22
 List all Filings 


19 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/09/21  Pro Dex Inc.                      8-K:1,2,9  11/05/21    3:90K                                    Edgar Filing LLC/FA
12/31/20  Pro Dex Inc.                      8-K:1,8,9  12/31/20    3:216K                                   Edgar Filing LLC/FA
12/11/20  Pro Dex Inc.                      8-K:5,9    12/07/20    2:99K                                    Edgar Filing LLC/FA
11/12/20  Pro Dex Inc.                      8-K:1,2,9  11/06/20    9:3.9M                                   Edgar Filing LLC/FA
 9/08/20  Pro Dex Inc.                      8-K:1,9     9/02/20    3:16M                                    Edgar Filing LLC/FA
10/01/19  Pro Dex Inc.                      8-K:1,2,9   9/30/19    2:35K                                    Edgar Filing LLC/FA
 9/07/18  Pro Dex Inc.                      8-K:1,2,8,9 9/04/18    5:610K                                   Edgar Filing LLC/FA
12/08/17  Pro Dex Inc.                      8-K:5,9    12/05/17    2:96K                                    Edgar Filing LLC/FA
 9/20/17  Pro Dex Inc.                      8-K:1,9     9/19/17    2:37K                                    Edgar Filing LLC/FA
10/17/16  Pro Dex Inc.                      DEF 14A    11/29/16    1:466K                                   Radius Fin’l Comp… Gp/FA
 5/14/15  Pro Dex Inc.                      10-Q        3/31/15   65:3.9M                                   Radius Fin’l Comp… Gp/FA
 7/17/13  Pro Dex Inc.                      8-K:1,9     7/15/13    2:39K                                    Radius Fin’l Comp… Gp/FA
 2/15/12  Pro Dex Inc.                      S-8         2/15/12    5:159K                                   Donnelley … Solutions/FA
 2/04/11  Pro Dex Inc.                      8-K:5,9     1/31/11    3:247K                                   EDGARX.com, LLC/FA
 6/18/10  Pro Dex Inc.                      8-K:5,9     6/17/10    3:56K                                    Toppan Merrill/FA
10/29/08  Pro Dex Inc.                      8-K:1,9    10/24/08    2:137K                                   EDGARX.com, LLC/FA
12/05/07  Pro Dex Inc.                      8-K:5,9    12/04/07    3:123K                                   EDGARX.com, LLC/FA
 8/23/07  Pro Dex Inc.                      8-K:1,9     8/17/07    2:342K                                   EDGARX.com, LLC/FA
 4/23/07  Pro Dex Inc.                      8-K:8,9     4/23/07    3:614K                                   EDGARX.com, LLC/FA
Top
Filing Submission 0001553350-22-000745   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 5, 6:27:43.3am ET